Molecular diagnosis in non-small-cell lung cancer: expert opinion on <i>ALK</i> and <i>ROS1</i> testingEsther Conde(HM Hospitales)Journal of Clinical PathologyApril 19, 202110.1136/jclinpath-2021-207490Cited by 45SaveCiteExport RISWatch citationsRelated PapersAssessment of a New ROS1 Immunohistochemistry Clone (SP384) for the Identification of ROS1 Rearrangements in Patients with Non–Small Cell Lung Carcinoma: the ROSING Study|Journal of Thoracic Oncology|2019|71